<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>City of Milwaukee - File #: 041308</title><link>https://milwaukee.legistar.com/Gateway.aspx?M=LD&amp;From=RSS&amp;ID=160173&amp;GUID=BCE73072-5133-4ADA-A7C2-96565D047E74</link><description /><generator>Legistar</generator><ttl>15</ttl><atom:link href="https://milwaukee.legistar.com/Feed.ashx?M=LD&amp;ID=160173&amp;GUID=BCE73072-5133-4ADA-A7C2-96565D047E74" rel="self" type="application/atom+xml" /><item><title>City of Milwaukee - File #: 041308</title><link>https://milwaukee.legistar.com/Gateway.aspx?M=LD&amp;From=RSS&amp;ID=160173&amp;GUID=BCE73072-5133-4ADA-A7C2-96565D047E74</link><guid isPermaLink="false">BCE73072-5133-4ADA-A7C2-96565D047E74-2023-02-14-19-57-55</guid><description>Title: Resolution authorizing settlement and release of the City of Milwaukee's claim against Abbott Laboratories, Takeda Chemical Industries, Ltd and TAP Pharmaceutical Products, Inc. in connection with purchases of the prescription drug Lupron under the City's Basic Health Plan. (City Attorney)</description><pubDate>Tue, 14 Feb 2023 19:57:55 GMT</pubDate></item></channel></rss>